Alzheimer's & Dementia

The Latest
More in Alzheimer's & Dementia

Case Report

Early Clinically Unsuspected Alzheimer’s Disease

Biomarkers can be important tools for diagnosis.

Georgette A. Khoury, MSN, APRN-BC; and Ira J. Goodman, MD


Dementia Insights: What Do Animal Models of Alzheimer’s Disease Tell Us?

Understanding pathologic mechanisms provides test beds for finding treatments.

Arnold M. Salazar; Amanda M. Leisgang; Andrew A. Ortiz; and Jefferson W. Kinney, PhD

About the Cover Artist

Cover Focus

Alzheimer’s Disease Drug Development & Emerging Therapies

We must all work together to accelerate clinical trials and create meaningful new therapies for Alzheimer’s disease.

Jeffrey L. Cummings, MD, ScD; and Kate Zhong, MD

Cover Focus

Brain Health & Dementia Risk Reduction

As preventative neurology becomes possible, it is worth providing risk reduction care to those at risk of Alzheimer’s disease dementia.

Nabeel Saif BA, MS; George Sadek, BA; Sonia Bellara, MBBS; Hollie Hristov, FNP; and Richard S. Isaacson, MD

Cover Focus

Sleep Disorders & Dementia

Sleep disorders are emerging as a biomarker for prodromal dementia.

Winnie Pao, MD

Cover Focus

Neuropsychiatric Aspects of Alzheimer’s Disease

Clinically significant neuropsychiatric symptoms need evidence-based treatment.

Zahra Goodarzi, BHSc (Hon), MD, MSc, FRCPC; and Zahinoor Ismail, MD, FRCPC

Cover Focus

Frontotemporal Dementias

Careful clinical, neuropsychologic, and imaging investigations make differential diagnosis of variants possible.

Ryan Taylor, MD; and Elizabeth Finger, MD

Cover Focus

Lewy Body Dementia

The second highest cause of dementia is highly variable.

James E. Galvin, MD, MPH

Cover Focus

Disclosing Risk Factors to Individuals Without Cognitive Impairment

Negative consequences of risk factor disclosure are likely to be most severe among people who are inadequately prepared to receive the information.

Joshua D. Grill, PhD

Cover Focus

Alzheimer’s Disease Biomarkers

Amyloid, tau, neurodegeneration (ATN)—where do we go from here?

Serge Gauthier, CM, CQ, MD, FRCPC; and Pedro Rosa-Neto, MD, PhD

Cover Focus

Neuropsychologic Assessment for Neurodegeneration

What is the value of neuropsychologic assessment in neurodegenerative diseases?

Jennifer Medina, PhD; and Sarah J. Banks, PhD, ABPP-CN

Cover Focus

Preclinical, Prodromal, and Dementia Stages of Alzheimer’s Disease

Identifying the correct stage of Alzheimer’s disease helps in managing risk, diagnosis, and management decisions.

Douglas W. Scharre, MD

Guest Medical Editor's Page

Alzheimer’s and Other Dementias—From Translation to Transformation

Progress in understanding dementia will take us from translation to transformation.

Jeffrey L. Cummings, MD, ScD


Dementia Insights: Cognitive Consequences of Perimenopause

A possible contribution of perimenopause should be considered when evaluating women with cognitive complaints.

Ronald Devere, MD, FAAN

Sleep & Neurodegenerative Disease

Sleep problems are common and treatable in neurodegenerative disorders, and may also be a treatable risk factor and early biomarker.

Raman K. Malhotra, MD

Sleep, Sleeplessness, & Neuropsychiatric Conditions

Sleep disturbances are symptoms of psychiatric conditions that can worsen prognosis; however, nonpharmacologic treatments are available and effective.

Fiona Barwick, PhD

Guest Medical Editor's Page

The Importance of Sleep

Sleep has a critical role in brain health and is an essential part of improving neurologic care for all of our patients.

Logan Schneider, MD

Sleep & Neurocognitive Performance

A daily adequate dose of healthy sleep is the most effective performance enhancement on the planet.

Mathias Basner, MD, PhD, MSc

Vascular Cognitive Impairment

Targeting risk factors may decrease vascular cognitive impairments.

Saud Alhusaini, MD, PhD; and Eric E. Smith, MD, MPH

Show More